Fig. 2From: Effect of pharmacogenomics testing guiding on clinical outcomes in major depressive disorder: a systematic review and meta-analysis of RCTForest plot of remission rate at week 4, 8, 12, and 24 comparing pharmacogenomic testing guided treatment versus usual care treatment. OR, odds ratio; CI, confidence intervalBack to article page